Hyper Corporation Inc.

KOSDAQ:A065650 Stock Report

Market Cap: ₩128.7b

Hyper Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hyun-Sang Muk

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Should Medifron DBT (KOSDAQ:065650) Be Disappointed With Their 48% Profit?

Mar 15
Should Medifron DBT (KOSDAQ:065650) Be Disappointed With Their 48% Profit?

Despite Lacking Profits Medifron DBT (KOSDAQ:065650) Seems To Be On Top Of Its Debt

Nov 29
Despite Lacking Profits Medifron DBT (KOSDAQ:065650) Seems To Be On Top Of Its Debt

CEO

Hyun-Sang Muk (65 yo)

no data

Tenure

Mr. Muk serves as Outside Director at Insung Information Co., Ltd., Chief Executive Officer and Representative Director at Hyper Corporation Inc. (formerly known as Medifron DBT Co., Ltd.).